Characterization and localization of citrullinated proteoglycan aggrecan in human articular cartilage

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Glant, Tibor T ^a   Ocsko, Timea ^a   Markovics, Adrienn ^a   Szekanecz, Zoltan ^b   Katz, Robert S ^a   Rauch, Tibor A ^a   Mikecz, Katalin ^a  

^a RUSH UNIVERSITY   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; ARGININE; CITRULLINE; DRUG MIXTURE; EPITOPE; TISSUE EXTRACT;

ADULT; AMINO ACID SEQUENCE; ARTICLE; ARTICULAR CARTILAGE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RESIDUE ANALYSIS; RHEUMATOID ARTHRITIS; ANTIBODY SPECIFICITY; BLOOD; CHEMISTRY; DRUG MIXTURE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; OSTEOARTHRITIS; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; WESTERN BLOTTING;

ADULT; AGGRECANS; ANTIBODY SPECIFICITY; ARGININE; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CITRULLINE; COMPLEX MIXTURES; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; PROTEIN STRUCTURE, TERTIARY; TISSUE EXTRACTS;

EID: 84961813354     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150784     Document Type: Article

References (47)

1. Fox DA. Etiology and Pathogenesis of Rheumatoid Arthritis. In: Koopman WJ, Moreland LW, editors. Arthritis and Allied Conditions: A Textbook of Rheumatology. Philadelphia: Lippincott Williams & Wilkins; 2005. pp. 1085-1102.
2. Firestein GS. Rheumatoid arthritis: Etiology and pathogeneis of rheumatoid arthritis. In: Ruddy S, Harris ED, Sledge CB, Kelley WN, editors. Kelley's Textbook of Rheumatology. Philadelphia, PA: W. B. Saunders Co.; 2005. pp. 996-1045.
3. Schellekens GA, De Jong BA, Van Den Hoogen FH, Van De Putte LB, Van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-281 PMID: 9421490
4. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford) 2002;41:809-814
5. Trouw LA, Huizinga TW, Toes RE. Autoimmunity in rheumatoid arthritis: different antigens-common principles. Ann Rheum Dis 2013;72 Suppl2:ii132-ii136 doi: 10.1136/annrheumdis-2012-202349 PMID: 23253931
6. Wegner N, Lundberg K, Kinloch A, Fisher B, Malmstrom V, Feldmann M, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010;233:34-54 doi: 10.1111/j.0105-2896.2009.00850.x PMID: 20192991
7. Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008;26:651-675 doi: 10.1146/annurev. immunol.26. 021607.090244 PMID: 18173373
8. Rantapaa-Dahlqvist S, De Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-2749 PMID: 14558078
9. Szodoray P, Szabo Z, Kapitany A, Gyetvai A, Lakos G, Szanto S, et al. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 2010;9:140-143 doi: 10.1016/j.autrev. 2009.04.006 PMID: 19427413
10. Van Venrooij WJ, Van Beers JJ, Pruijn GJ. Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 2011;7:391-398 doi: 10.1038/nrrheum.2011.76 PMID: 21647203
11. Von Delwig A, Locke J, Robinson JH, Ng WF. Response of Th17cellstoacitrullinatedarthritogenic aggrecan peptide in patients with rheumatoid arthritis. Arthritis Rheum 2010;62:143-149 doi: 10. 1002/art.25064 PMID: 20039419
12. Law SC, Street S, Yu CH, Capini C, Ramnoruth S, Nel HJ, et al. Tcell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis ResTher 2012;14:R118 doi: 10.1186/ar3848 PMID: 22594821
13. Aggarwal A, Srivastava R, Agrawal S. T cell responses to citrullinated self-peptides in patients with rheumatoid arthritis. Rheumatol Int 2013;33:2359-2363 doi: 10.1007/s00296-013-2731-2 PMID: 23543349
14. Karopoulos C, Rowley MJ, Ilic MZ, Handley CJ. Presence of antibodies to native G1 domain of aggrecan core protein in synovial fluids from patients with various joint diseases. Arthritis Rheum 1996;39:1990-1997 PMID: 8961903
15. Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 2005;44:40-50
16. Matsuo K, Xiang Y, Nakamura H, Masuko K, Yudoh K, Noyori K, et al. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther 2006;8:R175 PMID: 17125526
17. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003;197:489-501 PMID: 12591906
18. Snir O, Widhe M, Hermansson M, Von Spee C, Lindberg J, Hensen S, et al. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum 2009;62:44-52
19. Kinloch A, Lundberg K, Wait R, Wegner N, Lim NH, Zendman AJ, et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 2008;58:2287-2295 doi: 10.1002/art. 23618 PMID: 18668562
20. Zhao X, Okeke NL, Sharpe O, Batliwalla FM, Lee AT, Ho PP, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther 2008;10:R94 doi: 10.1186/ar2478 PMID: 18710572
21. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-361 PMID: 12748655
22. Glant TT, Radacs M, Nagyeri G, Olasz K, Laszlo A, Boldizsar F, et al. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis. Arthritis Rheum 2011;63:1312-1321 doi: 10.1002/art. 30261 PMID: 21305522
23. Glant TT, Mikecz K, Poole AR. Monoclonal antibodies to different protein-related epitopes of human articular cartilage proteoglycans. Biochem J 1986;234:31-41 PMID: 2423072
24. Glant TT, Mikecz K, Roughley PJ, Buzás E, Poole AR. Age-related changes in protein-related epitopes of human articular-cartilage proteoglycans. Biochem J 1986;236:71-75 PMID: 2431678
25. Glant T, Hadházy C, Mikecz K, Sipos A. Appearance and persistence of fibronectin in cartilage. Specific interaction of fibronectin with collagen type II. Histochemistry 1985;82:149-158 PMID: 3997552
26. Glant TT, Cs-Szabo G, Nagase H, Jacobs JJ, Mikecz K. Progressive polyarthritis induced in BALB/c mice by aggrecan from human osteoarthritic cartilage. Arthritis Rheum 1998;41:1007-1018 PMID: 9627010
27. Glant TT, Mikecz K. Proteoglycan aggrecan-induced arthritis. A murine autoimmune model of rheumatoid arthritis. Methods Mol Med 2004;102:313-338 PMID: 15286393
28. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis Rheum 1988;31:315-324 PMID: 3358796
29. Glant TT, Kamath RV, Bardos T, Gál I, Szanto S, Murad YM, et al. Cartilage-specific constitutive expression of TSG-6 protein (product of tumor necrosis factor α-stimulated gene 6) provides a chondroprotective, but not anti-inflammatory, effect in antigen-induced arthritis. Arthritis Rheum 2002;46:2207-2218 PMID: 12209527
30. Lundberg K, Nijenhuis S, Vossenaar ER, Palmblad K, Van Venrooij WJ, Klareskog L, et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005;7:R458-R467 PMID: 15899032
31. Bicker KL, Subramanian V, Chumanevich AA, Hofseth LJ, Thompson PR. Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination. J Am Chem Soc 2012;134:17015-17018 doi: 10.1021/ja308871v PMID: 23030787
32. Senshu T, Sato T, Inoue T, Akiyama K, Asaga H. Detection of citrulline residues in deiminated proteins on polyvinylidenedifluoride membrane. Anal Biochem 1992;203:94-100 PMID: 1524220
33. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006;22:195-201 PMID: 16301204
34. Bordoli L, Kiefer F, Arnold K, Benkert P, Battey J, Schwede T. Protein structure homology modeling using SWISS-MODEL workspace. Nat Protoc 2009;4:1-13 doi: 10.1038/nprot.2008.197 PMID: 19131951
35. Sayle RA, Milner-White EJ. RASMOL: biomolecular graphics for all. Trends Biochem Sci 1995;20:374 PMID: 7482707
36. Sandy JD, Verscharen C. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo. Biochem J 2001;358:615-626 PMID: 11535123
37. Buzas E, Mikecz K, Brennan FR, Glant TT. Mediators of autopathogenic effector cells in proteoglycaninduced arthritic and clinically asymptomatic BALB/c mice. Cell Immunol 1994;158:292-304 PMID: 7923385
38. Glant TT, Buzas EI, Finnegan A, Negroiu G, Cs-Szabo G, Mikecz K. Critical role of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol 1998;160:3812-3819 PMID: 9558085
39. Rosenberg L. Structure of proteoglycans. In: Burleigh PMC, Poole AR, editors. Dynamics of Connective Tissue Macromolecules. Amsterdam: Elsevier-North Holland; 1975. pp. 105-124.
40. Buzas E, Vegvari A, Murad YM, Finnegan A, Mikecz K, Glant TT. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis. Cell Immunol 2005;235:98-108 PMID: 16185673
41. Misjak P, Bosze S, Horvati K, Pasztoi M, Paloczi K, Holub MC, et al. The role of citrullination of an immunodominant proteoglycan (PG) aggrecan T cell epitope in BALB/c mice with PG-induced arthritis. Immunol Lett 2013;152:25-31 doi: 10.1016/j.imlet.2013.03.005 PMID: 23578666
42. De Jong H, Berlo SE, Hombrink P, Otten HG, Van Eden W, Lafeber FP, et al. Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T cell responses in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 2010;69:255-262 doi: 10.1136/ard.2008.103978 PMID: 19213744
43. Szanto S, Bárdos T, Szabo Z, David CS, Buzás E, Mikecz K, et al. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background. Arthritis Rheum 2004;50:1984-1995 PMID: 15188376
44. Taylor P, Gartemann J, Hsieh J, Creeden J. A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis. Autoimmune Dis 2011;2011:815038 doi: 10.4061/2011/815038 PMID: 21915375
45. Van De Stadt LA, De Koning MH, Van De Stadt RJ, Wolbink G, Dijkmans BA, Hamann D, et al. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis Rheum 2011;63:3226-3233 doi: 10.1002/art.30537 PMID: 21792832
46. Thiele GM, Duryee MJ, Dusad A, Hunter CD, Lacy JP, Anderson DR, et al. Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis. Int Immunopharmacol 2012;13:424-431 doi: 10.1016/j.intimp. 2012.05.007 PMID: 22626832
47. Sakkas LI, Bogdanos DP, Katsiari C, Platsoucas CD. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment. Autoimmun Rev 2014;13:1114-1120 doi: 10.1016/j. autrev. 2014.08.012 PMID: 25182207